SCHEMBL9182829

SCHEMBL9182829

C=CC(=O)OCCOc1ccc(C(C)(C)c2c(Br)c(Br)c(OCCOC(=O)C=C)c(Br)c2Br)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.51
ALDH1A1 P00352 10/20 0.40
KDM4E B2RXH2 8/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
GAA P10253 1/20 0.39
POLB P06746 2/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HTT P42858 1/20 0.36
TSHR P16473 3/20 0.35
HPGD P15428 1/20 0.35
TP53 P04637 2/20 0.35
HIF1A Q16665 2/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
PPARA Q07869 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14173110 0.85 THRB (0.65) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL137572 0.85 THRB (0.65) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL4384798 0.84 POLB (0.45) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL15592010 0.82 THRB (0.57) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL7631129 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL12281676 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL19770675 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL1618613 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL20394042 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA
SCHEMBL16804047 0.81 THRB (0.60) THRBALDH1A1KDM4ESMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3569591-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC Global Technologies B.V. (NL) 2019-11-20 EP disclosed
US-20190337895-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2019-11-07 US disclosed
US-10435368-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-10-08 US disclosed
EP-3172188-B1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-09-04 EP disclosed
US-20170166528-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-15 US disclosed
EP-3172188-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC Global Technologies B.V. (NL) 2017-05-31 EP disclosed
WO-2016014629-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-01-28 WO disclosed
EP-0382312-B1 A curable polyphenylene ether resin composition and a cured resin composition obtainable therefrom ASAHI CHEMICAL IND (JP) 1995-07-12 EP disclosed
US-5218030-A Storage stability; chemical and heat resistance, dimensional stability; electronics ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1993-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190337895-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, HSPBP1 THRB 4557/4885ALDH1A1 821/4885KDM4E 4787/4885
US-20170166528-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, HSPBP1 THRB 4557/4885ALDH1A1 821/4885KDM4E 4787/4885
US-10435368-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB1, HSPBP1 THRB 4557/4885ALDH1A1 821/4885KDM4E 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.